TAK Dividend History & Yield
Takeda Pharmaceutical Company Limited · NYSE
Upcoming dividend payments
| Ex-date | Pay date | Per share | Per 100 shares | Status |
|---|---|---|---|---|
| Sun, Oct 4, 2026 (in 25 days) | Oct 18, 2026 | $0.339 | $33.90 | Estimated |
| Tue, Apr 6, 2027 (in 209 days) | Apr 20, 2027 | $0.339 | $33.90 | Estimated |
Estimated dates and amounts are projected from TAK's recent payment pattern and will be replaced by declared figures when the company announces them. Total over the next 12 months: about $0.678 per share.
Dividend payment history
Last 3 payments per share. RegularSpecial
Annual dividends per share
How much TAK do you need for monthly income?
| Target income | Shares needed | Capital at today's price | Per year |
|---|---|---|---|
| $100 / month | 1,770 | $32,425 | $1,200 |
| $500 / month | 8,850 | $162,124 | $6,000 |
| $1,000 / month | 17,700 | $324,248 | $12,000 |
Based on the forward yield of 3.70%. $10,000 in TAK would currently pay about $370 a year ($31 a month on average). Model reinvestment and growth →
TAK dividend history
| Ex-date | Pay date | Amount | Change |
|---|---|---|---|
| Mar 31, 2025 | — | $0.339 | +4.0% |
| Sep 30, 2024 | — | $0.326 | +11.6% |
| Mar 27, 2024 | — | $0.292 | — |
TAK dividend increases & cuts
Market-wide changes →No change to TAK's regular dividend detected in the last year of data.
Detected from the regular payment stream; supplemental and special dividends are excluded. Pro members get an email the morning a holding raises or cuts.
Payout risk check
We do not have enough data to score TAK's payout risk yet.
This is a rule-based screen computed from public data, not a rating or a recommendation. Read our guide to yield traps for what the signals mean.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands.
Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. First dividend on our records: Mar 27, 2024. 3 payments tracked. Data last refreshed Sep 8, 2026. Spotted a mistake? Report it and we'll fix it.
TAK dividend FAQ
When is TAK's next ex-dividend date?
TAK's next ex-dividend date is Oct 4, 2026 (in 25 days, estimated from its semi-annual schedule). You must own the shares before that date to receive the payment of about $0.339 per share, expected on Oct 18, 2026.
How often does TAK pay dividends?
TAK pays dividends twice a year, 2 times a year. The most recent payment was $0.339 per share with an ex-date of Mar 31, 2025.
What is TAK's dividend yield?
TAK's forward dividend yield is 3.70% based on its indicated annual payout.
How much does TAK pay per share?
TAK pays about $0.339 per share each half-year, which works out to roughly $0.678 per share a year. 100 shares would collect about $67.80 a year.
Has TAK grown or cut its dividend?
TAK has raised its annual dividend for 1 consecutive year.
How many shares of TAK do I need to earn $100 a month?
At the current forward yield of 3.70%, you would need about 1,770 shares of TAK (roughly $32,425 invested at today's price) to collect $1,200 a year, or $100 a month on average, before taxes. Payments arrive twice a year, so the monthly figure is an average.
Similar dividend stocks
| Symbol | Type | Price | TTM yield | Annual / share | Frequency | Next ex-date | Trend |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly and Company | Stock | $1,123.91 | 0.60% | $6.92 | Quarterly | Nov 13 Est. | |
| JNJJohnson & Johnson | Stock | $269.17 | 1.96% | $5.36 | Quarterly | Nov 24 Est. | |
| ABBVAbbVie Inc. | Stock | $248.86 | 2.74% | $6.92 | Quarterly | Oct 14 Est. | |
| MRKMerck & Co., Inc. | Stock | $148.46 | 2.26% | $3.40 | Quarterly | Sep 15 Declared | |
| UNHUnitedHealth Group Incorporated | Stock | $400.84 | 2.23% | $9.28 | Quarterly | Sep 14 Declared | |
| NVSNovartis AG | Stock | $137.70 | 3.47% | $4.773 | Annual | Mar 11 Est. | |
| AZNAstraZeneca PLC | Stock | $160.04 | 1.35% | $4.306 | Semi-annual | Feb 18 Est. | |
| TMOThermo Fisher Scientific Inc. | Stock | $603.02 | 0.30% | $1.88 | Quarterly | Sep 15 Declared |